A Phase 2 interventional study of Ivermectin and Placebo in Plane Warts, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 5 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Al-Azhar University · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Warts with a site in Egypt — 5 open to participants now, 5 under way, 1 of them phase 3. Warts · Egypt.
Among the 30 studies in Warts with a site in Egypt, this one is the 6th largest by enrollment of the 26 interventional ones that give a count, is one of 2 that started in 2025, is one of 6 in phase 2, and was the 29th registered.
172 studies on the registry are indexed under Warts; 36 are open to participants now.
Browse Warts studies →5 of the 30 studies in Warts with a site in Egypt are open now. Recruiting first, the newest first:
Kafrelsheikh University · Sites in Egypt
Ages 18–50
Cairo University · Sites in Egypt
Ages 18–70
Zagazig University · Sites in Egypt
Ages 9+
Sohag University · Sites in Egypt
Ages 18+
Sohag University · Sites in Egypt
Ages 18–60 · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 19 Warts studies recruiting now, 11 (58%) set no upper age limit and 8 (42%) stop at 75 or younger; 12 take children under 18; 1 takes healthy volunteers.
This study: 5 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 9 · Phase 3 5 · Phase 4 3
First in 2017; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 80 is above the median of 70 across 156 interventional studies indexed under Warts.
Median enrollment 62 across the 26 interventional studies, 100 across the 4 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 30 has an industry lead sponsor. The 10 most frequent:
Al-Azhar University is the lead sponsor of 536 studies on the registry; 172 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Al-Azhar University has 1 study filed under Warts — fewer than ten, so there is no comparison to draw.
2 of the studies in Warts with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07937007Kafrelsheikh UniversityVitamin D3 Versus Methotrexate Versus Saline Injections for Plantar Warts | 2026-11 |
| NCT07543926Sohag UniversityNew Treatment of Common Wart | 2026-11-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 30 studies in Warts with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the efficacy of ivermectin in the treatment of plane warts( flat warts). patients diagnosed with plane warts will be included to assess the clearance ratre of the lesions.
Inclusion Criteria: • Clinical and dermoscopic diagnosis of the plane warts.
Exclusion Criteria:
Patients with other types of warts (e.g., common, plantar, genital).
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive topical ivermectin cream applied twice daily to plane warts for 3 months
Drug: Ivermectin
Patients will receive oral ivermectin once weekly for 3 months
Drug: Ivermectin
Other: Placebo
Other: Placebo
An antiparasitic medication evaluated for its immunomodulatory and antiviral efficacy in clearing plane warts. it will be administered to patients according to their assigned group protocol.
Patients in the control group will receive placebo,they will undergo standard clinical observation and follow up to monitor the natural course of the plane warts.
percentage of patients achieving complete clearance of plane warts
Time frame: 3 months
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jun 2025 to primary completion in Jul 2026, 13 months.
Of 18 phase 2 interventional studies under Warts, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 23. This study's 13 months is close to that.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 9, 2026: start Jun 2026 → Jun 2025, primary completion Jun 2026 → Jul 2026 and completion Jun 2027 → Jul 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ivermectin